OrbiMed Advisors
-
UK-based KaNDy Therapeutics raises $32.5 million Series C round, led by US firm
Longitude Capital leads round worth £25 million, which KaNDy will use to advance its non-hormonal menopause drug into Phase IIb clinical trial this year.
-
Do you advise self-insured employers? You Can Help Us!
Take part in this survey and share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health and navigation.
-
OrbiMed’s secret sauce: A Q&A with Founder Samuel Isaly (Part One)
“People who punch time cards are not likely those who discover new drugs,” OrbiMed Managing Partner Samuel Isaly said in a fascinating discussion at the BIO CEO conference in New York.
-
OrbiMed-backed LogicBio raises $4M for hemophilia gene therapy
Fledgling startup LogicBio Therapeutics has raised $4 million from OrbiMed Advisors for its hemophilia gene therapy therapeutic candidate.
-
Guardant Health announced an almost $100M Series D round for its cancer blood test
The Redwood City, Calif.-based company has raised nearly $100 million in Series D financing led by OrbiMed Advisors.
-
Healthcare venture firm OrbiMed launching $300M Israeli investment fund
If it’s anything like its first fund, OrbiMed’s new Israeli investment fund will invest $5 million to $20 million in each of 12 to 15 companies – much like the first fund.
-
Devices & Diagnostics, Pharma, Startups
OrbiMed draws in more healthcare strategics in nearly $1 billion royalty and credit fund
Healthcare investor OrbiMed announced its second debt and royalty fund on Monday and continued to […]
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Devices & Diagnostics, Hospitals, Startups
GE invests in Afib market, helps minimally invasive imaging and mapping startup close $28M Series B round
The growing A-fib market continues to gain the attention of the major players this week: […]
-
Devices & Diagnostics, Health IT, Pharma, Startups
These are the most active VCs in healthcare since 2012
As investments in life science companies have dipped over the past few years, some investors […]
-
Relypsa snatches $80M for drug to treat high potassium in kidney disease, diabetes
Patients with kidney disease, diabetes and heart failure can develop elevated potassium levels that can lead to serious complications. Relypsa – which has secured nearly $200 million since its founding – plans to take its drug to phase 3 trials this year.
-
‘Universal blood’ technology coming from Velico Medical
Velico Medical Inc. sold some of its royalty rights to OrbiMed Advisors LLC for an […]
-
Lung disease diagnostics company superDimension lands $25M
superDimension Inc. has raised $24.8 million, according to a report in Israeli media. The startup based in Plymouth, Minnesota, with offices in Israel and Germany is developing GPS-like technology designed to detect early stages of lung cancer.
-
Athersys board member resigns
As of Sept. 9, Michael Sheffery, a general partner with New York-based venture firm OrbiMed Advisors, no longer is a member of Athersys’ board.